These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9306423)

  • 41. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
    Chung SD; Lai MK; Chueh SC
    BJU Int; 2008 Aug; 102(4):519. PubMed ID: 18699962
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical effect of long-term administration of PSK in a combination in patients with malignant urologic cancer].
    Niijima T; Koiso K; Ueno A; Kawabe K; Umeda T; Kobayashi K; Akaza H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):540-2. PubMed ID: 7184410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
    McKenney JK; Amin MB; Young RH
    Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bone metaplasia of the bladder associated with urothelial tumor. A clinical case].
    Fernández Fernández A; Pacheco Blanco R; Fernández Ruíz M; Gil Fabra J; Otero Mauricio G
    Actas Urol Esp; 1998; 22(10):864-6. PubMed ID: 9949578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.
    Oosterlinck W; Solsona E; Akaza H; Busch C; Goebell PJ; Malmström PU; Ozen H; Sved P
    Urology; 2005 Dec; 66(6 Suppl 1):75-89. PubMed ID: 16399417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
    J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey".
    Giudice GC; Sonpavde GP
    Int J Urol; 2024 Aug; 31(8):943-944. PubMed ID: 38825971
    [No Abstract]   [Full Text] [Related]  

  • 50. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [BCG in the treatment of superficial transitional cell carcinoma of the urinary bladder].
    Leibovici D; Zisman A; Lindner A
    Harefuah; 1999 Apr; 136(8):628-33. PubMed ID: 10955074
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
    Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
    Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aetiology, diagnosis and management of urothelial tumours of the renal pelvis and ureter.
    Maddineni SB; Clarke NW; Sutherland DE; Jarrett TW
    BJU Int; 2008 Nov; 102(9 Pt B):1302-6. PubMed ID: 19035896
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facing treatment of non-urothelial bladder cancers in the immunotherapy era.
    Grilo I; Rodrigues C; Soares A; Grande E
    Crit Rev Oncol Hematol; 2020 Sep; 153():103034. PubMed ID: 32622321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Superficial bladder carcinoma -- trend of less aggressive therapies].
    Friedrich MG
    Aktuelle Urol; 2006 Jul; 37(4):254-6. PubMed ID: 16955957
    [No Abstract]   [Full Text] [Related]  

  • 57. Re: HER2 as a Target in Invasive Urothelial Carcinoma.
    Chang SS
    J Urol; 2016 Dec; 196(6):1637-1639. PubMed ID: 27845103
    [No Abstract]   [Full Text] [Related]  

  • 58. [Subsequent upper urothelial cancer following bladder tumor].
    Kuruma H; Ao T; Murayama M; Mizoguchi H; Koshiba K
    Hinyokika Kiyo; 2002 Apr; 48(4):199-202. PubMed ID: 12048930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial: urothelial tumors--liberal applications of conservative approaches.
    Droller MJ
    J Urol; 2003 Mar; 169(3):936-7. PubMed ID: 12576816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.